Development of Sequence-Optimized Nitroreductase for Retroviral Replicating Vector (RRV)-Mediated Prodrug Activator Gene Therapy in Human Glioma Models

被引：0
|
作者：
Collins, Sara A. [1 ]
Inagaki, Akihito Inagaki [1 ]
Tai, Chien-Kuo [2 ]
Logg, Christopher R. [3 ]
Searle, Peter F. [4 ]
Tangney, Mark [5 ]
Kasahara, Noriyuki [1 ,6 ]
机构：
[1] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA
[2] Natl Chung Cheng Univ, Dept Biomed Sci, Chiayi, Taiwan
[3] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA
[4] Univ Birmingham, Sch Canc Sci, CR UK Canc Ctr, Birmingham, W Midlands, England
[5] Univ Coll Cork UCC, Cork Canc Res Ctr, Cork, Ireland
[6] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA 94143 USA
来源：
MOLECULAR THERAPY | 2020年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
347
引用
收藏
页码：157 / 157
页数：1
相关论文
共 50 条
  • [41] Retroviral replicating vector-mediated suicide gene therapy for canine cancers
    Fukuda, Emiko S.
    Noguchi, Shunsuke
    Takarada, Toru
    Kasahara, Noriyuki
    Kubo, Shuji
    CANCER SCIENCE, 2024, 115 : 1794 - 1794
  • [42] Prodrug activator gene therapy mediated by prostate-specific replicating retrovirus vectors
    Kamijima, Shuichi
    Kimura, Takahiro
    Haga, Kazunori
    Hiraoka, Kei
    Inagaki, Akihito
    Logg, Christopher R.
    Kao, Chinghai
    Bochner, Bernard H.
    Ichikawa, Tomohiko
    Kasahara, Noriyuki
    CANCER RESEARCH, 2011, 71
  • [43] Clinical development of retroviral replicating vector Toca 511 for gene therapy of cancer
    Collins, Sara A.
    Shah, Ashish H.
    Ostertag, Derek
    Kasahara, Noriyuki
    Jolly, Douglas J.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (09) : 1199 - 1214
  • [44] RRV-MEDIATED PRODRUG ACTIVATOR GENE THERAPY COMBINED WITH ALLOREACTIVE T CELL IMMUNOTHERAPY FOR MALIGNANCIES IN THE CNS
    Kato, Y.
    Hickey, M.
    Treger, J.
    Erickson, K.
    Haga, K.
    Malone, C.
    Inagaki, A.
    Kruse, C.
    Kasahara, N.
    CYTOTHERAPY, 2015, 17 (06) : S51 - S52
  • [45] Replication-competent retrovirus vector-mediated prodrug activator gene therapy in experimental models of human malignant mesothelioma
    Kubo, Shuji
    Tamamoto, Atsuko
    Tamaoki, Tomoko
    Terada, Nobuyuki
    Maeyama, Yoshihiro
    Okamura, Haruki
    Kasahara, Noriyuki
    JOURNAL OF GENE MEDICINE, 2014, 16 (7-8): : 270 - 270
  • [46] Replication-competent retrovirus vector-mediated prodrug activator gene therapy in experimental models of human malignant mesothelioma
    Kawasaki, Y.
    Tamamoto, A.
    Takagi-Kimura, M.
    Maeyama, Y.
    Yamaoka, N.
    Terada, N.
    Okamura, H.
    Kasahara, N.
    Kubo, S.
    CANCER GENE THERAPY, 2011, 18 (08) : 571 - 578
  • [47] Replication-competent retrovirus vector-mediated prodrug activator gene therapy in experimental models of human malignant mesothelioma
    Y Kawasaki
    A Tamamoto
    M Takagi-Kimura
    Y Maeyama
    N Yamaoka
    N Terada
    H Okamura
    N Kasahara
    S Kubo
    Cancer Gene Therapy, 2011, 18 : 571 - 578
  • [48] Prodrug activator gene therapy for brain tumors by Retroviral Replicating Vectors delivered via allogeneic cell carriers: translational update
    Kamijima, Shuichi
    Hickey, Michelle
    Inagaki, Akihito
    Hiraoka, Kei
    Takahashi, Masamichi
    Tam, Quincy
    Faure-Kumar, Emmanuelle
    Treger, Janet
    Bogan, Brooke
    Malone, Colin
    Erickson, Kate
    Kato, Yuki
    Liau, Linda
    Kruse, Carol
    Kasahara, Noriyuki
    HUMAN GENE THERAPY, 2012, 23 (10) : A95 - A95
  • [49] Dual-Vector Prodrug Activator Gene Therapy Using Retroviral Replicating Vectors Derived from Amphotropic Murine Leukemia Virus and Gibbon Ape Leukemia Virus
    Kubo, Shuji
    Takagi-Kimura, Misato
    Logg, Christopher R.
    Hermann, Kip
    Kasahara, Noriyuki
    MOLECULAR THERAPY, 2015, 23 : S215 - S215
  • [50] Development of a double-copy bicistronic retroviral vector for human gene therapy
    Wiznerowicz, M
    Fong, AZC
    Hawley, RG
    Mackiewicz, A
    GENE THERAPY OF CANCER, 1998, 451 : 441 - 447
12345